Current Clinical Research Studies for Alzheimer's Disease

If you or your loved would like to learn more about any of the following clinical research studies, please contact us and one of our study coordinators will be in touch with you.

Study 1

A Phase 2B/3, Double-blind, Randomised, Placebo-controlled 48-week Safety and Efficacy Trial of Anavex2-73 for the Treatment of Early Alzheimer’s Disease

ANAVEX2-73 is a new small molecule that has been shown in previous research studies to improve mental activities that are involved in learning, remembering and using general daily knowledge. These results may indicate that ANAVEX2-73 has protective properties on the brain neurons that are usually damaged in Alzheimer’s disease.

NeuroCentrix logo

Do you or your loved one have Alzheimer’s Disease?

You may qualify for a clinical trial
Tell us how to contact you